The diagnosis and management of many conditions in andrology have been greatly influenced by recent pharmacological, surgical and basic science advances. One of the greatest challenges in this discipline is to keep abreast of the many dynamic changes in this field. An internationally acclaimed faculty has been assembled to provide this update, with presentations on topics such as Reproductive function in young male cancer survivors: when oncologists need andrologists, Functional Amyloid in the Epididymis: A Protective Mammalian Biofilm, Sperm RNA Biomarkers of Testicular Dysfunction, Mechanisms of sertoli cell immune regulation, Update on clinical trials utilizing stromal vascular fraction for management of erectile dysfunction, and Role of Pig Models in Preserving and Regenerating Male Fertility. During the plenary sessions, attendees will have the opportunity to participate in question and answer sessions.
Practicing community and academic urologists, Ph.D researchers, graduate students, andrology lab personnel, physician extenders in fertility and urology practices, D.Vm. practitioners and candidates with reproductive focus
2019 ASA Annual Meeting
There have been many recent advances in the basic science, translational science and clinical understanding of male reproductive health. Urologists, basic, and translational scientist should be up-to-date on the latest advances, research efforts, and treatment recommendations regarding conditions such as regenerative medicine, effects of environmental exposures on male reproductive health, the latest advance in reproductive technologies, and the contemporary clinical treatment of sexual function. Practitioners need to be updated on the advances in diagnostic modalities and treatment options for these conditions. Many collaborating Ph.D researchers working in reproductive biology and cell biology do not have an awareness of the clinical management of these conditions, their relatively high prevalence, and the need for an increased understanding of underlying biology of these conditions. Researchers will benefit from awareness of the epidemiology of these conditions, both in terms of their commonality and their predisposition to other urologic and general disease. Furthermore, an understanding of the epidemiologic impact of the treatment for these conditions (in terms of risk to offspring) is vital.
An awareness of future directions for research is useful to the audience as well and updated reviews will help identify future targets for research and novel treatments in fertility medicine.
A review of these topics will prove hugely useful to urologists and other MD’s, Ph.D researchers, DVm’s and trainees as well as physician extenders in andrology and laboratory professionals working in fertility medicine.
At the conclusion of the ASA 44th Annual Conference, attendees will be able to:
- Identify factors that may be affecting fecundity from diet, lifestyle, and the environment.
- Review the updated and newly identified gaps in knowledge and training of young andrologists.
- Examine the effectiveness of epigenetic patterns in IVF/ICSI outcomes.
- Recognize how Folic acid supplements impact the sperm DNA methylome.
- Recognize the consequences of paternal exposure to environmental and reproductive toxicants.
- Identify the major protein in human/mouse sperm.
- Determine if human sperm contain histones and if so, what is the amount compared to that in somatic cells.
- Define sperm epigenome.
- Determine if aging affects sperm quality.
- Explain the major effects of aging on sperm genome and epigenome.
- Describe the function of sperm centrosome in fertilization and where the centrosome comes from.
- Define extracellular vesicles (EV) and identify the contents of EVs.
- Describe the biomarkers for UTIs.
- Describe the basis for Cap-Score-based diagnostic for male infertility.
- Identify the sperm biomarkers for testis injury and how these biomarkers are are formed.
- Explain the basis of stem cell therapy for erectile dysfunction.
- Identify the type of stem cells being used for treating ED and their safety.
- Describe the application of Sertoli cell transplantation in andrology clinics.
- Explain how to do Sertoli cell transplantation in animal models.
- Identify the methods available in theory to preserve male fertility.
- Explain how germ cell transplantation works in mice and pigs.
- Describe the potential applications of male germ cell transplantation in andrology practice.
2019 ASA Clinical Symposium Men’s Sexual Health Update
One of the most common reasons our patients seek andrological care to improve sexual function. There is evidence that male sexual function has declined over the past half century with investigators attempting to confirm, understand, and reverse the trends. Examination of diet, lifestyle, and the environment on sexual function has led to some interesting observations and opportunities for improvement. However, a place remains for medical and surgical treatments as well. Looking to the future, new therapies are currently in human trials with data continued to be released.
At the conclusion of the ASA Clinical Symposium, attendees should be able to:
- Review the updated available treatment options for Peyronie’s Disease.
- Discuss the off label usage of intralesional injection of collagenase for Peyronie’s Disease.
- Describe the cutting edge methods for managing Chronic Orchalgia.
- Examine the evidence behind innovative but unproven techniques for treatment of Erectile Dysfunction.
- Discuss the current understanding of the availability of penile transplantation.
- Describe the updated success of completed penile transplantation patients and longitudinal complications.